GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, ...
April 10 2014 - 11:15AM
Business Wire
Levi & Korsinsky announces that a class action lawsuit has
been commenced in the United States District Court for the District
of Oregon on behalf of holders of Galena Biopharma, Inc. (“Galena”
or the “Company”) (Nasdaq: GALE) securities between November 6,
2013 and February 14, 2014.
For more information, click here:
http://zlk.9nl.com/galenabiopharma-gale.
The complaint alleges that throughout the Class Period, Galena
made false and/or misleading statements that led to the artificial
inflation of Galena’s stock price, allowing its Chief Executive
Officer to sell $3.8 million worth of his Galena stock.
On February 12, 2014, an article featured on TheStreet.com
alleged Galena was engaging in a misleading campaign aimed at
boosting its stock price, alleging that investor relations firm The
DreamTeam Group had published articles under aliases promoting the
Company’s stock without disclosing their sponsorship. Then on
February 14, 2014, Galena acknowledged that it had paid the
investor relations firm The DreamTeam Group to promote the
Company.
If you suffered a loss in Galena you have until May 5, 2014 to
request that the Court appoint you as lead plaintiff. Your ability
to share in any recovery doesn’t require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E.
Levi, Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/galenabiopharma-gale.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut, and Washington D.C. The firm has
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.30 Broad Street - 24th FloorNew York, NY 10004Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From Apr 2024 to May 2024
SELLAS Life Sciences (NASDAQ:SLS)
Historical Stock Chart
From May 2023 to May 2024